Venture capital firm Syncona Partners has committed to invest up to £34m in a £35m series-A funding round for newly launched UK-headquartered cell therapy company Quell Therapeutics.
Windhoist Holdings is Star Capital's sixth acquisition from its Strategic Assets III vehicle
Both Palatine Private Equity Fund III and IV used Evercore as their placement agent
GP deploys capital from its DBAG Fund VII, which held a final close on its €1bn hard-cap in 2016
Pemberton's most recent fundraise brings the direct lender's assets under management to €5.5bn